Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DK-21-004

The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional)

Closed on March 9, 2022.

Posted
March 17, 2021
Close date
March 9, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
5
5 new
Median first-year cost
$715,709
$3,425,933 in all
Institutions
5
5 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. ALBERT EINSTEIN COLLEGE OF MEDICINE1
  2. SCRIPPS RESEARCH INSTITUTE, THE1
  3. UNIVERSITY OF FLORIDA1
  4. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
  5. YALE UNIVERSITY1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-T (O2))4
  2. Special Emphasis Panel (ZDK1 GRB-T (J4))1
5 awards under RFA-DK-21-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2023Leveraging Human iPSC-derived beta-cells to Probe Antigen Specificity of Anti-islet Memory T Cells in T1D1R01DK135080-01Teyton, LucSCRIPPS RESEARCH INSTITUTE, THE, CAFirst-year cost $762,477Study section ZDK1
FY2023Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D1R01DK135052-01Kibbey, Richard GMamula, Mark JYALE UNIVERSITY, CTFirst-year cost $747,657Study section ZDK1
FY2023Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes1R01DK135081-01Mathews, Clayton EOstrov, David AQian, Wei-JunUNIVERSITY OF FLORIDA, FLFirst-year cost $715,709Study section ZDK1
FY2023The "dark immunopeptidome" as a source of CD8 T cell epitopes in type 1 diabetes1R01DK135079-01Dilorenzo, Teresa PPurcell, AnthonyALBERT EINSTEIN COLLEGE OF MEDICINE, NYFirst-year cost $616,624Study section ZDK1
FY2022Examining the role of CVB in the generation of beta cell neoantigens and targeted approaches at therapeutic intervention1R01DK132583-01Piganelli, Jon DUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $583,466Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-17-0.3.6. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-21-004: The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) | ConductScience ScienceDex